SCRiPTS Revenue

Nanotechnology Research • Ghent, Flemish Region, Belgium • 1-10 Employees

SCRiPTS revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at SCRiPTS

Guy Msomi

CEO

Company overview

Headquarters	Campus Sterre - Krijgslaan 281 S3, Gent, 9000, BE
Website	ugent.be
NAICS	541713
Employees	1-10

About SCRiPTS

The SCRiPTS group, based in the Department of Chemistry at Ghent University, welcomes you to our page! Our group is chaired by Prof. dr. Klaartje De Buysser and Prof. dr. Isabel Van Driessche. The research of SCRiPTS is defined by two main pillars: - Controlled synthesis of metal oxide nanocrystals, ligand design and nanocrystal surface chemistry, and the application of nanocrystals in medical imaging, contrast-enhanced composites and catalysis. - Solution processing of functional thin films for piezoelectric, ferroelectric and electro-optical applications

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

SCRiPTS has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

SCRiPTS has never raised funding before.

Frequently asked questions

SCRiPTS is located in Ghent, Flemish Region, BE.

SCRiPTS generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

SCRiPTS has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SCRiPTS has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at SCRiPTS

Guy Msomi

CEO

4.8

40,000 users